These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13903975)

  • 21. OBSERVATIONS ON THE FURTHER ATTENUATION OF MEASLES VIRUS AND ON LIVE VACCINES PREPARED FROM HIGHLY ATTENUATED LINES OF VIRUS.
    CHU CM; KU YF; CHANG YH
    Chin Med J; 1964 Aug; 83():483-96. PubMed ID: 14174535
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines.
    Okada H; Sato TA; Katayama A; Higuchi K; Shichijo K; Tsuchiya T; Takayama N; Takeuchi Y; Abe T; Okabe N; Tashiro M
    Arch Virol; 2001; 146(5):859-74. PubMed ID: 11448026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuated measles vaccine in Nigerian children.
    KATZ SL; MORLEY DC; KRUGMAN S
    Am J Dis Child; 1962 Mar; 103():402-5. PubMed ID: 14454409
    [No Abstract]   [Full Text] [Related]  

  • 24. Inactivated measles virus vaccine. II. Prevention of natural and experimental measles with the vaccine.
    FELDMAN HA; NOVACK A; WARREN J
    JAMA; 1962 Feb; 179():391-7. PubMed ID: 13892136
    [No Abstract]   [Full Text] [Related]  

  • 25. FURTHER OBSERVATIONS ON IMMUNIZATION WITH LIVE ATTENUATED MEASLES VIRUS VACCINE BY INHALATION.
    OKUNO Y
    Arch Gesamte Virusforsch; 1965; 16():294-9. PubMed ID: 14322881
    [No Abstract]   [Full Text] [Related]  

  • 26. Serological and epidemiological effects and influence factors of primary immunization with current live attenuated measles vaccine (Hu191) among infants aged 6-15 months.
    Youwang Y; Ping W; Feng C
    Vaccine; 2001 Feb; 19(15-16):1998-2005. PubMed ID: 11228370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IMMUNIZATION WITH LIVE ATTENUATED MEASLES VIRUS VACCINES: FIVE YEARS' EXPERIENCE.
    KATZ SL
    Arch Gesamte Virusforsch; 1965; 16():222-30. PubMed ID: 14322868
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and immunologic observations on two lines of attenuated measles vaccine virus upon passage in chick embryo cell culture.
    Chun H; T'eh-chang H; Kuo-hua T; Shou-teh C; Wen-huan W; Chi-ming C; Yu-fen K; Chü-yeh Y; Lan H
    Chin Med J (Engl); 1975 Jul; 1(4):283-6. PubMed ID: 810334
    [No Abstract]   [Full Text] [Related]  

  • 29. Prior DNA vaccination does not interfere with the live-attenuated measles vaccine.
    Premenko-Lanier M; Rota P; Rhodes G; Bellini W; McChesney M
    Vaccine; 2004 Jan; 22(5-6):762-5. PubMed ID: 14741170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 31. FURTHER STUDY OF THE USE OF LIVE ATTENUATED MEASLES-VIRUS VACCINE.
    CHU FT; CHANG IH; SUNG HY; LING CC
    Paediatr Indones; 1964; 149():42-8. PubMed ID: 14279960
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on measles in Thailand. VI. A clinical trial of "CAM 70" measles virus vaccine in home-dwelling children.
    Sangkawibha N; Ueda S; Tuchinda P; Sakuntanaga P; Sunthonsaratul A
    Biken J; 1973 Dec; 16(4):167-71. PubMed ID: 4799209
    [No Abstract]   [Full Text] [Related]  

  • 33. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
    Julik E; Reyes-Del Valle J
    J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation and characterisation of Edmonston-Zagreb measles virus.
    Ikić D; Juzbasić M; Beck M; Hrabar A; Cimbur-Schreiber T
    Ann Immunol Hung; 1972; 16(0):175-81. PubMed ID: 4679646
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile].
    Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Solari G; Concha F
    Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
    Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
    J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live measles vaccine: a 21 year follow up.
    Miller C
    Br Med J (Clin Res Ed); 1987 Jul; 295(6589):22-4. PubMed ID: 3113599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuated measles vaccine in children with acute leukemia.
    MITUS A; HOLLOWAY A; EVANS AE; ENDERS JF
    Am J Dis Child; 1962 Mar; 103():413-8. PubMed ID: 14474744
    [No Abstract]   [Full Text] [Related]  

  • 39. A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults.
    Simon JK; Pasetti MF; Viret JF; Mischler R; Muñoz A; Lagos R; Levine MM; Campbell JD
    Hum Vaccin; 2007; 3(2):54-8. PubMed ID: 17312403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus.
    Norrby E; Enders-Ruckle G; Meulen V
    J Infect Dis; 1975 Sep; 132(3):262-9. PubMed ID: 1159329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.